8-K ·Filed Apr 14, 2026

WLK

WESTLAKE CORP
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001193125-26-153703
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

Traders should monitor for further litigation developments, including court rulings on the settlement and potential exposure from unresolved indirect purchaser claims, which could lead to additional financial liability.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WLK ▼ -36.80% at T+60d
SHORT call ✓ call won +36.80% · α vs SPY +45.04% · entry $117.84 → $74.48
Entry anchored
Apr 13, 03:59 PM ET
via exchange tick
T+1d
-2.20%
call +2.20% · α +2.97%
$115.25
settled 6mo ago
T+5d
-2.04%
call +2.04% · α +3.43%
$115.44
settled 5mo ago
T+20d
-17.21%
call +17.21% · α +23.51%
$97.56
settled 5mo ago
T+60d
-36.80%
call +36.80% · α +45.04%
$74.48
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Westlake Corp agreed to pay $67 million to settle antitrust litigation with direct purchasers related to alleged price-fixing of PVC pipe and fittings. The settlement is subject to court approval, and claims by indirect purchasers remain pending.

Key Facts

  • Westlake agreed to pay $67 million to settle antitrust claims with direct purchasers (DPPs) in the PVC Pipe Antitrust Litigation.
  • The settlement is subject to preliminary and final court approval.
  • Claims by indirect purchaser plaintiffs remain pending and are not resolved by this settlement.
  • The lawsuits allege that Westlake and other manufacturers conspired to fix prices of PVC pipe and fittings in the U.S.
  • The motion for preliminary approval was filed on April 13, 2026.

Financial Impact

$67 million cash outflow if approved, representing a material liability.

cashlegal reservesnet income

Risk Factors

  • Additional financial exposure from ongoing indirect purchaser claims.
  • Reputational damage and potential for further regulatory scrutiny in the chemicals sector.
  • Risk that the settlement is not approved, leading to protracted litigation.

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-153703
Document: 0001193125-26-153703-index-headers.html0001193125-26-153703
Document: 0001193125-26-153703-index.html0001193125-26-153703
Document: 0001193125-26-153703.txt0001193125-26-153703
15 reports for WLK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +33.76%Mar 27, 2026
Filters
Rows
Reports for WLK — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$74.23 $62.31▼ −16.06%▼ −16.38%$63.50 (−14.46%)
Aug 14, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$78.21 $70.02▼ −10.47%▼ −8.49%$63.50 (−18.81%)
Aug 4, 2026
8w ago
8-K
BULLISH ★ 6/10
$80.63 $74.23▼ −7.94%▼ −6.70%$63.50 (−21.25%)
Jul 21, 2026
10w ago
Press Release
BEARISH ★ 7/10
$76.22 $77.52▼ −1.71%▲ +0.86%$63.50 (+16.69%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$84.33 $77.04▼ −8.64%▼ −8.84%$63.50 (−24.70%)
Jun 14, 2026
15w ago
Institutional Cluster
MIXED ★ 5/10
$87.45 $76.07▼ −13.01%▼ −12.26%$63.50 (−27.39%)
May 5, 2026
21w ago
8-K
BEARISH ★ 7/10
$104.29 $86.83▲ +16.74%▲ +21.70%$63.50 (+39.11%)
Apr 20, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$115.44 $91.46▼ −20.77%▼ −25.69%$63.50 (−44.99%)
Apr 14, 2026
24w ago
8-K
BEARISH ★ 7/10
$117.84 $97.56▲ +17.21%▲ +23.51%$63.50 (+46.11%)
Apr 6, 2026
25w ago
8-K
NEUTRAL ★ 4/10
$119.51 $114.07▼ −4.55%▼ −13.53%$63.50 (−46.87%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (64h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access